Clinical DIMENSIONThe Effects of Vasopressin on the Renal System in Vasodilatory ShockGessner, Patty ACNPAuthor Information Patty Gessner, ACNP, is the Clinician III for Critical Care at Alexian Brothers Medical Center, Elk Grove Village, Ill. She has 14 years clinical experience in a combined ICU/CCU. Responsibilities include educator and clinical coordinator of the continuous renal replacement therapy for patients in acute and chronic renal failure. Address correspondence and reprint requests to: Patty Gessner, ACNP, Critical Care, Alexian Brothers Medical Center, 800 Biesterfield Road, Elk Grove Village, IL 60007 ([email protected]). Dimensions of Critical Care Nursing: January 2006 - Volume 25 - Issue 1 - p 1-8 Buy Take the CE Test AbstractIn Brief An estimated 700,000 cases of sepsis occur each year in the United States alone, over half of which will develop renal failure. Of those that develop renal failure, 70% will die. This article will examine how the use of vasopressin in sepsis may improve some aspects of renal function. The effects of vasopressin on the renal system in vasodilatory shock. Sepsis occurs far too often in critically ill patients and can lead to a myriad of other disease processes. Over half of patients with sepsis develop renal failure. This article discusses the use of vasopressin in sepsis and how it may improve renal function in these patients. © 2006 Lippincott Williams & Wilkins, Inc.